CPIM
LXRX icon

Columbia Partners Investment Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Columbia Partners Investment Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-92,734
Closed -$1.68M – 298
2016
Q3 		$1.68M Buy
+92,734
New +$1.49M 0.13% 206

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Columbia Partners Investment Management's LXRX Position: Q4 2016 in Review

Columbia Partners Investment Management sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2016, closing a stake of 92,734 shares — an estimated $1.68M sold.

Columbia Partners Investment Management first reported a position in LXRX in Q3 2016 and held it in 1 quarter. The position peaked at $1.68M in Q3 2016. 146 funds tracked by Wall St. Rank hold LXRX as of Q4 2016.

  • Columbia Partners Investment Management reported no remaining Lexicon Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Columbia Partners Investment Management sold 92,734 Lexicon Pharmaceuticals shares in Q4 2016, an estimated $1.68M.
  • Columbia Partners Investment Management first reported a position in Lexicon Pharmaceuticals in Q3 2016 and held it in 1 quarter.
  • Columbia Partners Investment Management's Lexicon Pharmaceuticals position peaked at $1.68M in Q3 2016.
  • 146 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2016.

Based on Columbia Partners Investment Management's 13F filing for Q4 2016, filed 13 Feb 2017.